BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 34526055)

  • 21. Central nervous system sulfatide deficiency as a causal factor for bladder disorder in Alzheimer's disease.
    He S; Qiu S; Pan M; Palavicini JP; Wang H; Li X; Bhattacharjee A; Barannikov S; Bieniek KF; Dupree JL; Han X
    Clin Transl Med; 2023 Jul; 13(7):e1332. PubMed ID: 37478300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfatide decrease in myelin influences formation of the paranodal axo-glial junction and conduction velocity in the sciatic nerve.
    Hayashi A; Kaneko N; Tomihira C; Baba H
    Glia; 2013 Apr; 61(4):466-74. PubMed ID: 23322453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role and metabolism of sulfatide in the nervous system.
    Eckhardt M
    Mol Neurobiol; 2008; 37(2-3):93-103. PubMed ID: 18465098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice.
    Balu D; Valencia-Olvera AC; Nguyen A; Patnam M; York J; Peri F; Neumann F; LaDu MJ; Tai LM
    Alzheimers Res Ther; 2023 Oct; 15(1):181. PubMed ID: 37858252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.
    Ramakrishnan H; Hedayati KK; Lüllmann-Rauch R; Wessig C; Fewou SN; Maier H; Goebel HH; Gieselmann V; Eckhardt M
    J Neurosci; 2007 Aug; 27(35):9482-90. PubMed ID: 17728461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trilobatin Alleviates Cognitive Deficits and Pathologies in an Alzheimer's Disease Mouse Model.
    Ding J; Huang J; Yin D; Liu T; Ren Z; Hu S; Ye Y; Le C; Zhao N; Zhou H; Li Z; Qi X; Huang J
    Oxid Med Cell Longev; 2021; 2021():3298400. PubMed ID: 34777683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic caloric restriction attenuates a loss of sulfatide content in PGC-1α-/- mouse cortex: a potential lipidomic role of PGC-1α in neurodegeneration.
    Kiebish MA; Young DM; Lehman JJ; Han X
    J Lipid Res; 2012 Feb; 53(2):273-81. PubMed ID: 22114039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specificity and potential mechanism of sulfatide deficiency in Alzheimer's disease: an electrospray ionization mass spectrometric study.
    Cheng H; Xu J; McKeel DW; Han X
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):809-18. PubMed ID: 14528918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of TREM2 expression exacerbates neuroinflammatory responses through TLR4-mediated MAPK signaling pathway in a transgenic mouse model of Alzheimer's disease.
    Ruganzu JB; Peng X; He Y; Wu X; Zheng Q; Ding B; Lin C; Guo H; Yang Z; Zhang X; Yang W
    Mol Immunol; 2022 Feb; 142():22-36. PubMed ID: 34959070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology.
    Haure-Mirande JV; Audrain M; Fanutza T; Kim SH; Klein WL; Glabe C; Readhead B; Dudley JT; Blitzer RD; Wang M; Zhang B; Schadt EE; Gandy S; Ehrlich ME
    Acta Neuropathol; 2017 Nov; 134(5):769-788. PubMed ID: 28612290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice.
    Vilella A; Bodria M; Papotti B; Zanotti I; Zimetti F; Remaggi G; Elviri L; Potì F; Ferri N; Lupo MG; Panighel G; Daini E; Vandini E; Zoli M; Giuliani D; Bernini F
    Brain Behav Immun; 2024 Jan; 115():517-534. PubMed ID: 37967665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and Perspectives.
    Wolfe CM; Fitz NF; Nam KN; Lefterov I; Koldamova R
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30587772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer's disease.
    Nasiri E; Sankowski R; Dietrich H; Oikonomidi A; Huerta PT; Popp J; Al-Abed Y; Bacher M
    Mol Med; 2020 Apr; 26(1):34. PubMed ID: 32303185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel role for apolipoprotein E in the central nervous system. Modulation of sulfatide content.
    Han X; Cheng H; Fryer JD; Fagan AM; Holtzman DM
    J Biol Chem; 2003 Mar; 278(10):8043-51. PubMed ID: 12501252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice.
    Ng RC; Cheng OY; Jian M; Kwan JS; Ho PW; Cheng KK; Yeung PK; Zhou LL; Hoo RL; Chung SK; Xu A; Lam KS; Chan KH
    Mol Neurodegener; 2016 Nov; 11(1):71. PubMed ID: 27884163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies.
    Ji B; Maeda J; Sawada M; Ono M; Okauchi T; Inaji M; Zhang MR; Suzuki K; Ando K; Staufenbiel M; Trojanowski JQ; Lee VM; Higuchi M; Suhara T
    J Neurosci; 2008 Nov; 28(47):12255-67. PubMed ID: 19020019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The lipid sulfatide is a novel myelin-associated inhibitor of CNS axon outgrowth.
    Winzeler AM; Mandemakers WJ; Sun MZ; Stafford M; Phillips CT; Barres BA
    J Neurosci; 2011 Apr; 31(17):6481-92. PubMed ID: 21525289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STC1 ameliorates cognitive impairment and neuroinflammation of Alzheimer's disease mice via inhibition of ERK1/2 pathway.
    Wang P; Li XL; Cao ZH
    Immunobiology; 2021 May; 226(3):152092. PubMed ID: 34004549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene co-expression networks identify Trem2 and Tyrobp as major hubs in human APOE expressing mice following traumatic brain injury.
    Castranio EL; Mounier A; Wolfe CM; Nam KN; Fitz NF; Letronne F; Schug J; Koldamova R; Lefterov I
    Neurobiol Dis; 2017 Sep; 105():1-14. PubMed ID: 28502803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
    Katsouri L; Georgopoulos S
    PLoS One; 2011; 6(7):e21880. PubMed ID: 21755005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.